1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Actimed Therapeutics Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) (S)-pindolol benzoate, Semaglutide, Placebo to (S)-pindolol benzoate - Obesity, Muscle Loss | Phase 2 | Recruiting | Actimed Therapeutics Ltd | 120 | 2025-06-23 | 2026-02-17 |
| Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV) Part 1 Group 1 Regime A (ACM-001.1), Part 1 Group 2 Regimen C (Pindolol), Part 2 Group D (Pindolol) - Cachexia | Phase 1 | Completed | Actimed Therapeutics Ltd | 51 | 2021-11-26 | 2023-10-10 |
Cachexia (1) · Muscular Atrophy (1) · Obesity (1)
Pindolol (1) · semaglutide (1)
Serbia (1) · United Kingdom (1)